Welcome to our dedicated page for Elbit Sys SEC filings (Ticker: ESLT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Elbit Systems Ltd (ESLT) SEC filings page provides access to the company’s U.S. regulatory disclosures as a foreign private issuer. Elbit Systems files an annual report on Form 20-F and current reports on Form 6-K under the Securities Exchange Act of 1934. These filings furnish information such as press releases, financial results, contract announcements, proxy materials and other corporate updates for investors who follow ESLT stock.
Form 6-K reports from Elbit Systems typically attach press releases covering topics like quarterly and semi-annual financial results, order backlog, major defense contracts, capital-raising transactions, rating agency reports, shelf prospectus developments in Israel and outcomes of annual general meetings of shareholders. For example, recent 6-K filings have furnished releases on second and third quarter 2025 results, large international contracts, tank upgrade programs, rocket artillery systems, and the extension of the company’s shelf prospectus in Israel.
Form 20-F, which is referenced in the company’s press releases, contains more comprehensive annual information, including audited financial statements, risk factors, a description of business segments and details on corporate governance. Together, these filings help explain how Elbit Systems presents its financial condition, results of operations, order backlog, funding activities and governance framework to U.S. regulators and investors.
On this page, users can review ESLT 6-K current reports, the latest 20-F annual report and related documents as they become available from EDGAR. AI-powered tools on the platform can assist by summarizing lengthy filings, highlighting key sections on topics such as revenue by segment, order backlog, capital structure and risk disclosures, and helping readers quickly locate information relevant to their analysis of Elbit Systems Ltd.
Elbit Systems executive Boaz Cohen filed an initial ownership report showing indirect holdings of two employee stock option grants held in trust. One grant covers 20,000 Ordinary Shares at an exercise price of $197.82 per share, expiring on December 19, 2028, vesting 40%/30%/30% from 2026 to 2028.
A second grant covers 5,000 Ordinary Shares at an exercise price of $912.60 per share, expiring on June 24, 2031, vesting 40%/30%/30% from 2028 to 2030. The options use a net exercise mechanism, so the actual shares received on exercise will be fewer than the underlying amounts.
Elbit Systems executive vice president Yoram Shmuely reported a combined option exercise, tax settlement, and share sale. On April 9, 2026, an employee benefit trust exercised 9,000 employee stock options on his behalf at $134.34 per share, resulting in 9,000 ordinary shares held for his benefit.
Of these shares, 1,346 were retained by Elbit Systems to pay the option exercise price, and 7,654 shares were then sold in an open-market transaction at $887.40 per share. After these transactions, no shares or options from this award remained in the trust. The options and resulting shares were held in trust, with Shmuely as sole beneficiary.
Elbit Systems Executive Vice President Vered Yehuda exercised employee stock options for 7,000 ordinary shares at an exercise price of $134.34 per share. The options and resulting shares were held in an employee benefit trust managed by IBI Trust Management, with Mr. Yehuda as sole beneficiary.
Of the 7,000 shares received, 1,047 shares were retained by Elbit Systems as payment of the option exercise price, and the remaining 5,953 shares were sold in open-market transactions at $887.40 per share. Following these transactions, the trust-held position in these ordinary shares was reduced to zero, and no related derivative options from this grant remain outstanding.
Elbit Systems executive Oren Yaacov Sabag, an Executive Vice President, exercised 10,000 employee stock options on April 9, 2026 at an exercise price of $134.34 per share, receiving an equal number of ordinary shares held in an employee benefit trust.
Of these shares, 1,496 were retained by Elbit Systems as payment of the option exercise price, while the remaining 8,504 shares were sold in the open market at $887.40 per share. Following these transactions, the trust held no shares from this option grant. The options had vested in four tranches between April 7, 2023 and April 7, 2026.
Elbit Systems Executive Vice President Ariel Jonathan exercised employee stock options for 9,000 ordinary shares at $134.34 per share, with the options and resulting shares held in an employee benefit trust. Of the acquired shares, 1,346 were retained by the company to pay the option exercise price and 7,654 shares were sold in the open market at $887.40 per share. Following these transactions, the trust no longer holds shares or options from this grant for Mr. Ariel.
Elbit Systems President and CEO Bezhalel Machlis reported a compensation-related option exercise and share sale through an employee benefit trust. On April 9, 2026, an employee stock option for 30,000 Ordinary Shares was exercised at $134.34 per share, with the options and resulting shares held in trust by IBI Trust Management for his benefit.
Following the exercise, 4,486 shares were retained by Elbit Systems to pay the option exercise price, and the remaining 25,514 shares were sold in open-market transactions at $887.40 per share. After these transactions, the trust’s position in these reported Ordinary Shares from this grant was reduced to zero, and no related derivative position remains visible in this filing.
Elbit Systems Ltd Executive Vice President Ran Kril reported an exercise-and-sale transaction involving employee stock options held in an employee benefit trust. He exercised 8,000 employee stock options at an exercise price of $134.34 per share, receiving the same number of ordinary shares indirectly through the trust. The company retained 1,197 shares to pay the option exercise price, and the remaining 6,803 shares were sold in the market at $887.40 per share. Following these transactions, no shares from this option grant remained in the trust.
Elbit Systems Executive Vice President Haim Daniel Delmar exercised employee stock options to acquire 9,000 ordinary shares of Elbit Systems Ltd. at $134.34 per share, held indirectly through an employee benefit trust.
The company retained 1,346 shares to pay the option exercise price, and the remaining 7,654 shares were sold in an open-market transaction at $887.40 per share. Following these transactions, the trust reported no remaining options or shares for this award.
Elbit Systems Ltd. reported a major new defense win, securing a contract worth approximately $750 million (€650 million) to supply its PULS rocket artillery systems to the Hellenic Armed Forces. The deal is part of an agreement between the Israeli and Hellenic defense ministries.
The contract will be executed over 4 years and followed by an additional ten-year support period. It covers PULS launchers and a broad munitions package, including training rockets, precision‑guided rockets for various ranges and loitering munitions. Elbit Systems will work with Greek industries on production, including technology transfer and know‑how sharing.
The company describes PULS as a flexible, cost‑effective artillery solution adaptable to wheeled and tracked platforms. Elbit Systems, which reported $7,938.6 million in revenues and an $28.1 billion order backlog for the year ended December 31, 2025, views this contract as further strengthening its long‑standing relationship with Greece and adding to its European customer base.
Elbit Systems Ltd Executive Vice President Haim Daniel Delmar received an award of 5,000 employee stock options, indirectly held in an employee benefit trust managed by IBI Trust Management. The options have an exercise price of 912.6000 per share and are exercisable into 5,000 Ordinary Shares.
The options vest in three tranches: 40% on March 24, 2028, 30% on March 24, 2029, and 30% on March 24, 2030, and expire on June 24, 2031. The plan uses a net exercise mechanism, so the actual shares delivered upon exercise will likely be fewer than 5,000. Mr. Delmar is the sole beneficiary of the options.